President, Chief Legal Officer
Brian Savage leads Lupin’s global Legal, Compliance and Intellectual Property Management Group (IPMG) functions, helping the company navigate the complex legal, regulatory and intellectual property landscape of the global pharmaceutical industry, drawing on deep expertise across these disciplines.
Prior to joining Lupin, Brian was interim Chief Legal Officer at Teva Pharmaceuticals, and held several other senior leadership roles at Teva before that, including leading the company’s global litigation strategy and serving as General Counsel for its U.S. Generics business. Earlier in his career, Brian practised law at Dechert LLP.
Brian holds a Juris Doctor (J.D.) from Yale Law School and a B.A., summa cum laude, from the University of Pennsylvania.
